The positive programmed death‐ligand 1 (PD‐L1) expression accompanied profiles of lymphocyte exhaustion, enriched inhibitory molecules and pro‐tumor populations and down‐modulation of most MHC class I members was correlated with a poor overall survival (OS) outcome in pancreatic cancer patients.11, 12. This evidence concerns the gene CD274 and pancreatic neoplasm.